Police said the investigation remains ongoing and officials caution that the information is preliminary at this time.

Dr. Vinay Prasad is back at the FDA less than two weeks after the White House pressed the head of the agency to remove him from his multiple agency leadership roles, an HHS spokesperson said Saturday.

Health Secretary Robert F. Kennedy Jr.'s decision to cut federal funding for mRNA vaccine research is the latest in a series ...

The uncertainty surrounds who will be able to get updated vaccines in coming months – shots created to protect against more ...

The Food and Drug Administration has rehired the vaccine chief who resigned just two weeks ago. Dr. Vinay Prasad led the ...

In late July, Prasad, a hematologist oncologist, said he was resigning because he “did not want to be a distraction to the ...

Vinay Prasad, a former critic of U.S. COVID-19 policies, returns to the FDA's Center for Biologics Evaluation and Research after briefly leaving. His tenure drew criticism, notably over the handling ...

At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for ...

Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...

Dr. Vinay Prasad was rehired Saturday to lead the FDA's Center for Biologics Evaluation and Research less than two weeks ...

Dr. Vinay Prasad’s rehiring was an unusual instance of a federal official targeted by the right-wing activist Laura Loomer ...

Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to his post, according to the Department of Health and Human Services ...